N	Concordance
1	l mitotane in the treatment of advanced adrenocortical cancer  (ACC) patien
2	redominantly affected. The frequency of adrenocortical cancer was 13% among pati
3	rest-derived cells and is used to treat adrenocortical cancer and neuroblastoma 
4	    in   the treatment of patients with adrenocortical cancer could be con
5	on the clinical course of patients with adrenocortical cancer.        Cancer 71(